InvestorsHub Logo
icon url

$UPERMAN

03/03/12 11:13 AM

#48501 RE: Carna4z #48498

RECENT COMPANY PRESS RELEASES

? Cannabis Science Issues Potential Revenues And Market Data for the New Cannabis Science Brand
OTC Products Business Wire(Fri Mar 2, 11:40AM EST)

? Cannabis Science’s COO Dr. Afaneh Provides Guidance On The Newest Over The Counter Product
Line To Be Released Business Wire(Thu Mar 1)

? Cancer Drug Market Evolves - Cannabis Science and ARIAD Pharmaceuticals Poised to Benefit
Marketwire(Mon Feb 27)

? Cannabis Science Chief Operating Officer Dr. Moe Afaneh, Pharm D., MBA, NRCC, Confirms Newest
Cannabis Science Brand Product Line & Begins Manufacturing and National Distribution Negotiations
to Immediately Release The New Product Line Business Wire(Fri Feb 24)

? Cannabis Science Presents Newest Case Photos of the 3rd Critical Squamous Cell Carcinoma Self-
Medicated Cannabis Patient with Clear Continued Improvement Business Wire(Thu Feb 23)

? A&E Begins Filming An 8-episode Documentary With Cannabis Science’s Newly Appointed Director of
Horticulture Bret Bogue; Focused On Bret Bogue, World Renowned Medical Cannabis Cultivator
Business Wire(Wed Feb 22)

? Cannabis Science Appoints Former Walgreens Executive Pharmacist Dr. Moe Afaneh, Pharm D., MBA,
NRCC, RNC as Chief Operating Officer (COO) To Immediately Bring the Cannabis Science Brand of
Products to the National Market Business Wire(Thu Feb 16)

? Cannabis Science Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, Its
Pharmaceutical Operations and Management Team While Bringing Cannabis Science Brand
Products For National Distribution Business Wire(Tue Feb 14)

? Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently
Completely Killed & Hair Re-growth Begins On New Healthy Skin From 2nd Self-Administering Cancer
Patient Business Wire(Tue Feb 7)

? Cannabis Science Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend,
Market Potential, and Anecdotal Reports Business Wire(Thu Feb 2)